Patent search ap:("UCB BIOPHARMA SRL") AND inv:"David John ABRAHAM" Page 1

1.

发明申请
METHOD FOR THE TREATMENT OF A SCLERODERMA DISEASE 有权

公开(公告)号：US20250026856A1

公开(公告)日：2025-01-23

申请号：US18711331

申请日：2022-11-17

Applicant: UCB BIOPHARMA SRL

Inventor： Timothy Scott JOHNSON , John ATKINSON , Jorg Hans Wilhelm DISTLER , David John ABRAHAM

IPC: C07K16/40 , A61P17/00

Abstract: The present invention relates to an anti-transglutaminase type 2 (TG2) antibody for use in the treatment of a scleroderma disease, such as localized or systemic scleroderma.

Patent Agency Ranking